65 Spam-Free Article(s) Found
Article Searches
Here's Why You Should Hold on to QIAGEN (QGEN) Stock Now http://www.zacks.com/stock/news/427904/heres-why-you-should-hold-on-to-qiagen-qgen-stock-now?cid=CS-ZC-FT-427904 Jun 11, 2019 - QIAGEN (QGEN) is enjoying investors' high confidence, courtesy of the QIAstat-Dx system.
QIAGEN-DiaSorin Union to Enhance QuantFERON for Lyme Disease http://www.zacks.com/stock/news/425750/qiagen-diasorin-union-to-enhance-quantferon-for-lyme-disease?cid=CS-ZC-FT-425750 Jun 06, 2019 - QIAGEN (QGEN) expects multi-site clinical validations for this new system during 2020 Lyme disease season.
QIAGEN (QGEN) Launches PIK3CA Kit for Breast Cancer Patients http://www.zacks.com/stock/news/420525/qiagen-qgen-launches-pik3ca-kit-for-breast-cancer-patients?cid=CS-ZC-FT-420525 May 28, 2019 - QIAGEN's (QGEN) therascreen PIK3CA Kit is the first companion diagnostic test to have attained premarket approval from the FDA.
QIAGEN (QGEN) to Win U. N. Accolade for QuantiFERON-TB Access http://www.zacks.com/stock/news/418385/qiagen-qgen-to-win-u-n-accolade-for-quantiferon-tb-access?cid=CS-ZC-FT-418385 May 23, 2019 - This acclaim marks a giant leap for QIAGEN (QGEN) in the field of tuberculosis diagnosis.
Qiagen NV (QGEN) Q1 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2019/05/07/qiagen-nv-qgen-q1-2019-earnings-call-transcript.aspx?source=iedfolrf0000001 May 07, 2019 - QGEN earnings call for the period ending March 31, 2019.
Qiagen NV (QGEN) CEO Peer Schatz on Q1 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4261076-qiagen-nv-qgen-ceo-peer-schatz-q1-2019-results-earnings-call-transcript?source=feed_sector_healthcare May 07, 2019 - Qiagen NV (NYSE:QGEN) Q1 2019 Earnings Conference Call May 07, 2019, 09:00 ET Company Participants John Gilardi - VP, Corporate Communications & IR Peer Schatz - CEO Roland Sackers - CFO Conferenc
Qiagen (QGEN) Tops Q1 Earnings Estimates http://www.zacks.com/stock/news/409754/qiagen-qgen-tops-q1-earnings-estimates?cid=CS-ZC-FT-409754 May 06, 2019 - Qiagen (QGEN) delivered earnings and revenue surprises of 3.85% and -0.76%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for QIAGEN (QGEN) http://www.zacks.com/stock/news/408467/why-earnings-season-could-be-great-for-qiagen-qgen?cid=CS-ZC-FT-408467 May 03, 2019 - QIAGEN (QGEN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Qiagen (QGEN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release http://www.zacks.com/stock/news/405026/qiagen-qgen-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q1-release?cid=CS-ZC-FT-405026 Apr 29, 2019 - Qiagen (QGEN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
QIAGEN Drives Molecular Diagnostics Suite With New Test Kit http://www.zacks.com/stock/news/382055/qiagen-drives-molecular-diagnostics-suite-with-new-test-kit?cid=CS-ZC-FT-382055 Apr 16, 2019 - QIAGEN (QGEN) introduces the FDA approved companion diagnostic test to help in guiding therapy in any cancer identification.

Pages: 1234567

Page 1>